awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37421058-1BB0900A-6CCA-4CBB-92BA-F4EA52453CE0
Q37421058-1BB0900A-6CCA-4CBB-92BA-F4EA52453CE0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37421058-1BB0900A-6CCA-4CBB-92BA-F4EA52453CE0
Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes.
P2860
Q37421058-1BB0900A-6CCA-4CBB-92BA-F4EA52453CE0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37421058-1BB0900A-6CCA-4CBB-92BA-F4EA52453CE0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36d7134247400106ed9f48c1951e0e75e4c9bed4
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus